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Patient recovery after infrainguinal bypass
grafting for limb salvage
Alexander D. Nicoloff, MD, Lloyd M. Taylor, Jr., MD, Robert B. McLafferty,
MD, Gregory L. Moneta, MD, and John M. Porter, MD, Portland, Ore.
Purpose: The outcome of infrainguinal bypass surgery for limb salvage has traditionally
been assessed by graft patency rates, limb salvage rates, and patient survival rates.
Recently, functional outcome of limb salvage surgery has been assessed by patient ambu-
latory status and independent living status. These assessments fail to consider the
adverse long-term patient effects of delayed wound healing, episodes of recurrent
ischemia, and need for repeat operations. An ideal result of infrainguinal bypass surgery
for limb salvage includes an uncomplicated operation, elimination of ischemia, prompt
wound healing, and rapid return to premorbid functional status without recurrence or
repeat surgery. The present study was performed to determine how often this ideal result
is actually achieved.
Methods: The records of 112 consecutive patients who underwent initial infrainguinal
bypass surgery for limb salvage 5 to 7 years before the study were reviewed for opera-
tive complications, graft patency, limb salvage, survival, patient functional status, time
to achieve wound healing, need for repeat operations, and recurrence of ischemia.
Results: The mean patient age was 66 years. The mean postoperative follow-up was 42
months (range, 0 to 100.1 months). After operation 99 patients (88%) lived indepen-
dently at home and 103 (92%) were ambulatory. There were seven perioperative deaths
(6.3%), and wound complications occurred in 27 patients (24%). By life table, the assist-
ed primary graft patency and limb salvage rates of the index extremity 5 years after oper-
ation were 77% and 87%, respectively, and the patient survival rate was 49%. At last fol-
low-up or death, 73% of the patients (72 of 99) who lived independently at home before
the operation were still living independently at home, and 70% (72 of 103) of those who
were ambulatory before the operation remained ambulatory. Wound (operative and
ischemic) healing required a mean of 4.2 months (range, 0.4 to 48 months), and 25
patients (22%) had not achieved complete wound healing at the time of last follow-up
or death. Repeat operations to maintain graft patency, treat wound complications, or
treat recurrent or contralateral ischemia were required in 61 patients (54%; mean, 1.6
reoperations/patient), and 26 patients (23.2%) ultimately required major limb amputa-
tion of the index or contralateral extremity. Only 16 of 112 patients (14.3%) achieved
the ideal surgical result of an uncomplicated operation with long-term symptom relief,
maintenance of functional status, and no recurrence or repeat operations.
Conclusions: Most patients who undergo infrainguinal bypass surgery for limb salvage
require ongoing treatment and have persistent or recurrent symptoms until their death.
A significant minority have major tissue loss despite successful initial surgery. Clinically
important palliation is frequently achieved by bypass surgery, but ideal results are dis-
tinctly infrequent. (J Vasc Surg 1998;27:256-66.)
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accurate assessment of wound healing, recurrence
of ischemia, and return to functional status,
patients were excluded from the study if they
remained alive but were lost to follow-up before 2
years.
Data were obtained from retrospective review of
patient records. Additional data were obtained
regarding deceased patients and patients whose
records did not contain adequate information by
interview of patients, surviving family members, and
referring physicians. The Oregon Bureau of Vital
Statistics provided information regarding the date
and cause of death for patients whose terminal care
was not provided at OHSU. Patients underwent IB
according to the principals previously described in
detail by our division.7-9 The important points
include preoperative and postoperative noninvasive
vascular laboratory testing, detailed preoperative
arteriography, use of autologous vein for infrain-
guinal grafts, and multiteam surgery.
After operation patients were seen as often as
necessary until wound healing was complete. Rou-
tine postoperative vascular laboratory surveillance of
vein grafts using duplex scanning was performed
every 3 months for the first postoperative year and
every 6 months thereafter. Graft stenoses discovered
by duplex scanning were confirmed by arteriography
and were electively repaired if they exceeded 50%
diameter reduction determined by arteriography, as
previously reported.10
Postoperative outpatient wound management
was supervised by the authors and performed by vis-
iting nurses. Risk factor reduction was supervised by
patients’ referring physicians. All patients received
daily aspirin therapy. Routine screening for hyperco-
agulable states was performed at the time of surgery.
Patients who had positive test results were treated
with long-term warfarin anticoagulation therapy
unless there were contraindications.
For the purposes of this study, perioperative risk
factors, indication for surgery, type of operation per-
formed, and conduit used were recorded from the
patient records. Operative results, including mortal-
ity and morbidity data, were also recorded from
patient records. Life table determination of assisted
primary graft patency rate, limb salvage rate, and
patient survival rate was performed according to the
suggested reporting standards of the Joint Vascular
Societies.2
Patient functional status was assessed by living
situation and ambulatory status before the indica-
tion for IB arose, in the subsequent postoperative
period, and at the time of last follow-up or death.
Results of lower extremity bypass surgery have
traditionally been assessed by graft patency rate, limb
salvage rate, and patient survival rate. Reporting
standards for these outcome variables have been
described and are widely used.1,2 Recently, increas-
ing emphasis has been placed on the importance of
integrating functional outcome measures with tradi-
tional assessments of patients who undergo lower
extremity revascularization for peripheral vascular
occlusive disease. Patient global health status,
including function and well-being, has been evaluat-
ed by questionnaires such as the one described by
the Medical Outcomes Study.3 Specific question-
naires pertaining to patients with peripheral vascular
occlusive disease have focused on non–limb-threat-
ening manifestations of the disease, particularly
intermittent claudication.4 The few studies that have
assessed functional outcomes in populations with
limb-threatening ischemia have been limited to
short-term follow-up.5,6
Previous functional outcome assessments have
not directly considered the adverse long-term
patient effects of delayed wound healing, episodes of
recurrent ischemia, and the need for repeat opera-
tions. Most surgeons would agree that an ideal result
after infrainguinal bypass (IB) for limb salvage
includes elimination of ischemia, uncomplicated
wound healing, and rapid return to premorbid func-
tional status without the need for repeat leg opera-
tions. Certainly, this is what is logically expected by
patients and frequently by referring physicians. The
present study was performed to determine how
often this ideal result is actually achieved.
METHODS
Patients included in the study underwent IB for
limb salvage at the Oregon Health Sciences Uni-
versity Hospital (OHSU) from December 1988 to
January 1991. This interval was chosen to include
only patients whose procedure was performed suf-
ficiently long ago to permit adequate assessment of
long-term outcome. Limb salvage indications for
surgery were defined as ischemic rest pain, ischemic
ulcers or gangrene, acute ischemia, and an ankle-
brachial pressure index less than 0.4. Patients who
met these criteria were included whether the oper-
ations were performed electively to treat chronic
ischemia or were performed urgently or emergent-
ly to treat acute worsening of ischemia. To elimi-
nate statistical errors from multiple observations,
only patients who underwent their first IB for limb
salvage at OHSU were included in the study. To
allow an adequate postoperative time period for an
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Living situation was classified as “home and inde-
pendent” if patients were living alone, with a spouse,
or with other family members; “home with assis-
tance” if patients required home health nursing; and
“dependent” if patients were living in a care facility
(such as a nursing home or foster home). Ambula-
tory status was classified as “ambulatory” if patients
walked independently or used a cane or walker, or
“nonambulatory” (wheelchair-bound or bed-
bound).
Wound healing was assessed by the occurrence of
wound-related complications and by the time
required for healing. Wounds were regarded as
healed when there was no epithelial defect and when
wound care, including dressings and ointments, was
no longer required. Wound-related complications
included need for repeat hospitalization or surgery
or need for additional wound-related treatment
(such as antibiotics or a visiting nurse) The time
required for healing of all wounds related to the pro-
cedure was recorded. The time required for healing
of operative incisions was recorded separately from
the time required for healing of ischemic wounds for
which the surgery was performed. The total time
recorded for healing of ischemic wounds included
the time required for healing of secondary opera-
tions performed to treat areas of ischemic ulceration
or gangrene (such as toe amputation or debride-
ment). Wound healing time for repeat ipsilateral
operations (such as graft revision or repeat grafting)
or subsequent contralateral operations was not
included in the total wound healing time, to permit
assessment of the results of the original operation
only and to eliminate the statistical problems of
repeat observations.
Secondary operations to treat the ischemic
lesions responsible for the original surgery were
recorded. Minor toe and foot amputations and foot
debridement performed after IB to complete treat-
ment of the original ischemic lesion were regarded
as part of the original operation rather than as repeat
surgery even if performed on a subsequent date.
Wound care required to complete this portion of the
treatment was not regarded as a wound complica-
tion. If more than one operation was required to
treat ischemic lesions (such as amputation after
debridement failed to heal or repeat debridement, or
skin grafting), the second and all subsequent proce-
dures were regarded as repeat operations. Repeat
operations to treat graft complications or recurrent
or contralateral disease were also recorded.
Patients were designated as having had an ideal
result if there were no operative complications, if
operative wounds and ischemic wounds healed with-
out complication, if repeat surgery was not neces-
sary, and if functional status returned to the level
that existed before the onset of the indication for IB.
RESULTS
During the 3-year study period, 133 patients
underwent IB for limb salvage for the first time at
OHSU. Twenty-one patients (16%) were lost to fol-
low-up less than 2 years from their initial operation
without record of death and were excluded from the
study, leaving 112 patients (84%) who constituted
the study group.
Demographic factors, risk factors, operative indi-
cations, procedures performed, and conduits used
for the 112 study patients are compared with those
for the 21 excluded patients in Table I. Operative
Table I. Patient demographics of study group and
patients lost to follow-up (LTF)
112 patients 21 patients
in study group (%) LTF (%) p*
Age (yr) 66.1 ± 14.0 68.3 ± 14.3 0.724
Male 56 43 0.258
Indication
Ulcer or gangrene 66 67 0.958
Rest pain 30 19 0.328
Acute ischemia 44 14 0.082
Hypertension† 64 57 0.534
Heart disease 61 62 0.918
Diabetes mellitus 53 43 0.409
Smoking (previous 67 81 0.221
or current)
Renal failure‡ 22 9 0.176
Stroke 8 28 0.009
Hyperlipidemia§ 29 33 0.702
Hypercoagulablell 8 14 0.382
Previous ipsilateral IB 19 24 0.591
Procedure
Femoropopliteal 41 52 0.337
Femorotibial 44 38 0.631
Femoropedal 4.5 0 0.324
Popliteal-tibial 6 10 0.584
Popliteal-pedal 4.5 0 0.324
Conduit
Reversed GSV 84 86 0.837
Alternate vein 10 5 0.458
Prosthetic 6 9 0.200
GSV, Greater saphenous vein.
*By c 2 analysis.
†Blood pressure 180/100 mm Hg or greater, or taking antihy-
pertensive medication.
‡Serum creatinine level 2.5 mg/dl or greater, requiring dialysis,
or history of renal transplant.
§Fasting serum cholesterol level 240 mg/dl or greater, or taking
lipid-lowering agents.
llDiagnosis of protein C or S deficiency, antithrombin III defi-
ciency, anticardiolipin antibody, lupus inhibitor, or hyperhomo-
cystinemia, or requiring chronic anticoagulation therapy.
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complications and deaths that occurred in the 112
study patients are compared with those that
occurred in the 21 excluded patients in Table II.
Except for a significant difference in the number of
previous strokes that had occurred in the excluded
patient group (28% vs 8%; p = 0.009), there were no
significant differences between the two groups. The
study population is therefore an appropriately repre-
sentative majority of the entire population of
patients who underwent IB for limb salvage during
the study period.
The mean duration of follow-up for study
patients was 42 months (range, 0 to 100.1 months).
Sixty-one patients died during follow-up at a mean
interval of 25 months after surgery (range, 0 to 95.6
months). The mean follow-up for the 51 surviving
patients was 62 months (range, 24.1 to 100.1
months).
Conventional analysis
The 6-month, 3-year, and 5-year assisted prima-
ry patency, limb salvage, and patient survival rates
calculated by life table methods are shown in Table
III.
Functional outcome
Ambulatory status. Before the onset of the
symptoms that caused the need for IB, 103 of the
112 study patients (92%) were ambulatory and nine
(8%) were nonambulatory. After operation, of the
103 patients who were ambulatory before surgery,
five (5%) died in the perioperative period, 87 (84%)
were ambulatory, and 11 (11%) were nonambulato-
ry. At last follow-up or death, 72 of the 103 patients
(70%) who were ambulatory before operation
remained ambulatory, and 26 (25%) were nonambu-
latory (Table IVA). Three of the nine patients (33%)
who were nonambulatory before operation regained
ambulation after operation and remained ambulato-
ry at last follow-up or death (Table IVA).
Living status. Living status before operation
was home and independent for 99 of 112 patients
(88%), home with assistance for 10 patients (9%),
and dependent for three patients (3%). After opera-
tion, of the 99 patients who were home and inde-
pendent before the operation, seven (7%) died in the
perioperative period, 65 (66%) were discharged
home and independent, 17 (17%) were discharged
home with assistance, and 10 (10%) were depen-
dent. Six of the 10 patients (60%) who lived at home
with assistance before operation resumed this status
at hospital discharge, and the other four (40%) were
dependent. All three patients who were dependent
before operation remained dependent. Overall, at
the time of last follow-up or death, 81 of 112
patients (72%) had maintained their preoperative liv-
ing status, 28 (25%; including seven patients who
died in the perioperative period) had declined in liv-
ing status, and no patients had an improvement in
living status. Information on living status at last fol-
low-up or death was not available regarding the
remaining three patients (3%). At the time of last fol-
low-up or death 72 of the 99 patients (73%) who
were home and independent before operation were
still home and independent, four (4%) were home
with assistance, and 14 (14%) were dependent; seven
(7%) died in the perioperative period, and no infor-
mation was available for the remaining two patients
(2%; Table IVB).
Living and ambulatory status. Before surgery,
96 of 112 patients (86%) were ambulatory and
home and independent. Of these 96 patients, 65
(68%) remained ambulatory and home and indepen-
dent at the time of last follow-up or death (Table
IVB).
Wound healing
Wound complications developed in 27 patients
(24%) after operation, requiring treatment with
antibiotics or nursing care or surgical debridement
and drainage. The mean time to complete healing of
all wounds, operative and ischemic, was 4.2 months
(range, 0.4 to 48 months). Table V shows the time
to wound healing for operative and ischemic
Fig. 1. Only 16 of 112 patients (14%) achieved an ideal
result. Of the 96 patients (86%) who failed to achieve an
ideal result, eight (8%) failed because of perioperative
death or complications only and 88 (92%) failed because
of long-term factors. Sixty-one of the 96 patients (64%)
required repeat surgery, 28 (29%) had a decrease in func-
tional status (ambulatory or living status), and 27 (28%)
had wound complications.
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wounds. By life table analysis, 24% of all patients had
unhealed wounds at 6 months after operation, 14%
at 1 year, 8% at 3 years, and 5% at 5 years. Twenty-
four of the 112 patients (22%) and 18 of 74 patients
(24%) who had ulcer or gangrene as the indication
for operation had not achieved complete wound
healing at the time of last follow-up or death.
Repeat operations
Repeat operations to maintain graft patency, to
treat ongoing, recurrent, or contralateral ischemia,
or to treat wound complications were required in 61
patients (54%). The mean number of repeat opera-
tions per patient during the study period was 1.6
(range, 0 to 10). These figures do not include 40
subsequent operations performed to treat the origi-
nal ischemic lesions, which for purposes of this study
were regarded as part of the original surgery even if
performed on a subsequent date, as described in
Methods. In all, 176 repeat operations were
required. Eighty-nine (51%) of the repeat operations
were vascular reconstructions (42 new grafts, 32
graft revisions, and 15 inflow procedures). Fifty-two
of the repeat operations (29%) were amputations (26
major and 26 minor). The remaining 35 repeat
operations (20%) consisted of wound debridement
and drainage or skin grafting (Table VI). Twenty-
seven patients (24%) required IB of their contralat-
eral extremity subsequent to undergoing IB of the
index extremity, and 63 of the total repeat opera-
tions (35%) were performed on the contralateral
extremity, for a mean of 0.5 contralateral extremity
operations per patient. By last follow-up or death,
15 patients (13%) required a subsequent major
amputation of the ipsilateral leg and 11 patients
(10%) required a subsequent major amputation of
the contralateral leg.
Ideal results
Sixteen of 112 patients (14%) had ideal surgical
results, which consisted of an uncomplicated opera-
tion with long-term symptom relief, maintenance of
functional status, uncomplicated wound healing,
and no recurrence or repeat operations regardless of
postoperative survival time. Failure to achieve an
ideal result was caused by operative death in seven
patients (7%), by perioperative complications in 25
patients (26%), by failure to regain or maintain pre-
operative functional status in 28 patients (29%), by
wound complications in 27 patients (28%), and by
the need for repeat surgery in 61 patients (64%; Fig.
1).
DISCUSSION
Early reports of IB for limb-threatening ischemia
cautioned against an overly aggressive surgical
approach because of poor graft patency, limb sal-
vage, and patient survival rates.11-13 As experience
with these operations increased and surgical tech-
nology, including lighting, instruments, and sutures
improved, surgeons’ technical skills also improved,
resulting in marked improvement in the patency and
limb salvage results reported for IB performed for
limb-threatening ischemia.7,14-21 The well docu-
mented poor outcomes after primary amputation
appeared to support an aggressive approach to limb
salvage.22-26 Marked improvement in patency and
limb salvage results characterized our own experi-
ence with IB for limb salvage, as was true for multi-
ple other groups.7,14-21
The present study was undertaken because of the
anecdotal observation that despite excellent patency
and limb salvage rates as judged by standard report-
ing practices, patients who underwent IB for limb
salvage in our clinic appeared to follow a clinical
course characterized by a frequent and ongoing
need for care, including repeat hospitalizations for
wound care and repeat surgery. An attempt to char-
acterize and quantitate this clinical observation,
Table II. Perioperative complications of the study
group and patients lost to follow-up
112 patients  21 patients
in study group LTF p*
Wound complications† 24% 19% 0.678
Myocardial infarction 9% 10% 0.461
Death 6% 0% 0.239
Congestive heart failure 4% 0% 0.354
Thrombosis 3% 5% 0.448
Hematoma 4% 5% 0.792
Respiratory failure 1% 5% 0.181
Renal failure 1% 0% 0.664
Stroke 1% 0% 0.664
Cardiac arrhythmia 1% 0% 0.664
*By c 2 analysis.
†Includes infection with or without repeat operation, seroma,
lymphocele, and dehiscence.
Table III. Life table analysis of conventional mea-
sures in the 112 study-group patients
Assisted primary Limb salvage Survival
patency(SE) (SE) (SE)
6 mo 93.1% (0.03) 94.9% (0.02) 81.3% (0.04)
3 yr 87.6% (0.04) 93.5% (0.03) 61.8% (0.05)
5 yr 77.3% (0.05) 86.9% (0.04) 49.0% (0.05)
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familiar to many surgeons, constituted the basis for
this study.
It is not the purpose of this paper to suggest that
the rapidly declining functional status and poor
long-term survival rate documented in the limb sal-
vage patient group are entirely or even primarily
caused by either lower extremity ischemia or by the
surgery performed for its treatment. Clearly, this is
not the case. Rather, it is abundantly clear that limb-
threatening ischemia is a manifestation of athero-
sclerosis that occurs in patients who are approaching
the end of life, at a time when functional status is fre-
quently declining rapidly and interval survival is
short. The data available for this retrospective study
did not permit determination of the specific causes
of decline in functional status or need for nursing
home placement. What is clear from this study is
that surgical treatment of the ischemic limb(s) by IB
appears to do little to change this state.
For several reasons, patency and limb salvage
data are less than ideal parameters for assessment of
results of limb salvage surgery. Most reports contain
the results of institutions’ entire experience with IB,
which means that many patients are included who
have short-term follow-up. The effect of “frontload-
ing” data evaluated by life table is to favorably bias
the results when long-term outcome is censored by
death of many patients, as described by Myers et
al.27 Patency assesses the results of an individual
operation. Limb salvage assesses the results of an
operation on a single limb. Neither parameter per-
mits assessment of the total effect of an operation on
the patient. After all, from the patient’s point of
view, it matters little whether a repeat operation
required after initially successful IB for limb salvage
is performed on the contralateral limb for new symp-
toms, on the ipsilateral limb for a wound problem,
on the ipsilateral limb for revision of a graft stenosis,
or on the ipsilateral limb for recurrent ischemia
caused by development of a stenosis in the inflow
vessel, although each of these events has a very dif-
ferent implication with respect to parameters that
assess the results of the original operation. From the
patient’s perspective, repeat hospitalization and
surgery, postoperative wound healing, and the nec-
essary clinic visits are indistinguishable from the
original episode. The current study documents that
wound complications and recurrent or persistent
ischemia of the ipsilateral or contralateral limb mean
that for many patients, once limb-threatening
ischemia occurs, the need for treatment is lifelong.
Recognizing this problem, recent efforts to eval-
uate the results of lower extremity bypass surgery
have included assessment of functional outcomes
after vascular surgery. Questionnaires such as those
described by the Medical Outcomes Study Approach
have been developed to assess patient global health
status and functioning.28 One questionnaire, the
Table IV A. Patient functional status—ambulation
Preoperative Operative Postoperative Status at last 
status death status follow-up or late death
Amb Nonamb Amb Nonamb
Ambulatory 103 (92%)* 5 (5%) 87 (84%) 11 (11%) 72 (70%) 26 (25%)
Nonambulatory 9 (8%)* 2 (22%) 3 (33%) 4 (44%) 3 (33%) 4 (44%)
Total 112 (100%) 7 (6%) 90 (80%) 15 (14%) 75 (67%) 30 (27%)
Table IV B. Patient functional status—living
Independ. Assisted Depend. Independ. Assisted Depend. No info
Independent 99 (88%)* 7 (7%) 65 (66%) 17 (17%) 10 (10%) 72 (73%) 4 (4%) 14 (14%) 2 (2%)
Assisted 10 (9%)* 6 (60%) 4 (40%) 6 (60%) 3 (30%) 1 (10%)
Dependent 3 (3%)* 3 (100%) 3 (100%)
Total 112 (100%) 7 (6%) 65 (58%) 23 (21%) 17 (15%) 72 (64%) 10 (9%) 20 (18%) 3 (3%)
Independent 96 (86%)* 54 (56%) 65 (68%)
and ambulatory
Amb, Ambulatory, Nonamb, nonambulatory (wheelchair, bedbound, or transfer only); Independent, home and independent; Depend,
dependent; No info; information not available.
*Percentages refer to total of 112 study patients.
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Peripheral Arterial Disease—Walking Impairment
Questionnaire (PAD-WIQ) developed by Regen-
steiner and colleagues, has been validated for assess-
ment of functional status in patients with claudica-
tion.4 No questionnaire has similarly been validated
for assessment of patients who have severe limb-
threatening ischemia. The RAND 36-Item Health
Survey 1.0, which is identical to the Medical Out-
comes Study Short Form, was applied to a group of
38 patients who underwent bypass grafting for limb
salvage by Duggan and colleagues.29 These authors
found no difference in health perceptions between
patients who had successful limb salvage and patients
who had failed bypass grafts that required amputa-
tion. It is tempting to conclude that the RAND 36-
Item Health Survey that was used simply did not
assess appropriate criteria to detect a difference. The
results of the present study, which document frequent
and prolonged wound complications, frequent need
for repeat surgery on both the ipsilateral and con-
tralateral legs, an appreciable incidence of late limb
loss, and progressive decline in functional status
strongly suggest that the results of Duggan and col-
leagues’ study may be disturbingly accurate.
Global health questionnaires may not adequately
assess parameters directly related to limb salvage
surgery. Previous studies from our own institution as
well as from others have suggested that patient ambu-
latory status and living status (parameters most direct-
ly related to limb salvage) are maintained shortly after
bypass surgery.5,30 That this is not the case in the
long-term is clearly documented in the present study,
in which only 68% of patients who were ambulatory
and living independently before surgery maintained
this status at the time of last follow-up or death. This
marked change from early to late postoperative status
means that studies of functional status of patients who
undergo lower extremity bypass operations must
include a majority with at least 3 years of follow-up.
It is unlikely that the present study consists of a
patient group with uniquely poor results. The
patient demographics, indication for surgery, opera-
tions performed, conduits used (Table I), and the
life table calculation of assisted primary patency rate,
limb salvage rate, and patient survival rate are well
within the range previously reported for IB for limb
salvage by many groups, including our own.7,14-21
Recently reported results from Great Britain also
document an appreciable requirement for use of
health care resources because of wound complica-
tions and the need for repeat surgery in the limb sal-
vage patient group.31,32
As assessed by the parameters of this study, ideal
results of IB are distinctly infrequent. Only 14% of
patients had an uncomplicated operation, relief of
symptoms, uncomplicated wound healing, no need
for repeat surgery, and maintenance of functional
status. For the 86% of patients who did not have
ideal results, wound care, repeat hospitalizations,
and repeat surgery, frequent clinic visits and declin-
ing functional status meant that a large portion of
the final months of life was occupied with treatment
of limb ischemia.
These mostly negative results must be viewed
with some caution. The retrospective nature of the
study meant that only the most broad parameters
regarding functional status could be determined.
Because 86% of patients were living independently
and were ambulatory before operation, none of
these patients could improve after operation, a situ-
ation that may have introduced negative bias into
the study. It is possible that a detailed prospective
study of functional status in patients who undergo
IB for limb salvage would have a different outcome.
CONCLUSION
Although clinically important palliation is fre-
quently achieved by IB for limb salvage, ideal results
are distinctly infrequent. Most patients who undergo
Table V. Time to wound healing of operative and
ischemic wounds in those patients that did heal
Operative Ischemic All 
wounds (mo) wounds (mo) wounds (mo)
Mean 1.9 5.2 4.2
Median 1.3 3.4 2.7
Range 0.4 to 10.1 0.4 to 48.3 0.4 to 48.3
SD 1.7 7.7 6.3
Mo, Months; SD, standard deviation.
Table VI. Repeat operations*
Type of operation Total number (%)
Wound debridement 32 (18.2)
Minor amputation 26 (14.8)
Skin grafting 3 (1.7)
Major amputation 26 (14.8)
New graft construction 42 (23.8)
Graft revisions 32 (18.2)
Inflow procedures 15 (8.5)
Total 176 (100)
*Figures include repeat operations to maintain graft patency; to
treat ongoing, recurrent, or contralateral ischemia; or to treat
wound complications. Figures do not include 40 subsequent
operations performed to treat the original ischemic lesions, as
described under Methods.
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IB for limb salvage require ongoing treatment for
significant portions of the remainder of their lives. In
view of these results, continued evaluation of alter-
nate approaches to therapy, including nonoperative
treatment and primary amputation, appears warrant-
ed. It is interesting to speculate that whereas we have
spent the past several decades defining the technical
limits of what can be done surgically to treat limb-
threatening ischemia, we may spend the next period
defining when such surgery should be performed.
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Dr. James O. Menzoian (Boston, Mass.). In assessing
the outcomes of lower extremity revascularization, it is
important to define certain ground rules by which the
results of the clinical intervention can be assessed. In
reviewing reported results, it is often difficult to decide
whether these reports are measuring and defining the out-
comes of an operation or defining the outcome from the
point of view of the patient. For example, a bypass graft-
ing procedure that was performed for a nonhealing ulcer
may in fact continue to function, but in a small percentage
of patients the ulcer may persist. In this circumstance the
bypass graft is functioning well; however, the patient is not
doing well.
Dr. Nicoloff and his colleagues have reported to us today
on the results of infrainguinal bypass surgery for limb salvage
in 112 patients. In addition to the conventional analysis of
results with limb salvage and graft patency rates, they report
on the functional outcome of their patients who underwent
the surgery. They define an ideal result for infrainguinal
bypass grafting for limb salvage to include elimination of
ischemia, prompt wound healing, and a rapid return to their
premorbid functional status without recurrence. Their assist-
ed primary graft patency and limb salvage rates at 5 years are
respectable, as one would expect from this group. Some of
their findings, however, are quite sobering.
For the period of follow-up, which was a mean of 42
months, the patient survival rate was 49%. At last follow-
up or death, 73% of the patients who were living indepen-
dently before operation were still living independently,
and 70% of those who were ambulatory before operation
remained ambulatory. The operative wound and the
ischemic wound for which the bypass procedure was per-
formed required an average of 4.2 months to heal, and
22% of the patients had not achieved complete wound
healing at the time of last follow-up. Fifty-four percent of
the patients had to undergo another operation during the
period of follow-up. Twenty-three percent of the patients
ultimately required a major amputation. Only 16 of 112
patients achieved the ideal surgical result. I must reiterate
that these sobering results occurred in spite of what we
would consider to be an excellent assisted primary graft
patency rate of 77% and a limb salvage rate of 87% at 5
years. I would like to ask the authors a few questions.
You have used a kind of functional outcome assess-
ment of your patients but have not done so using any of
the traditional quality-of-life assessment tools such as the
Rand 36 Item Health Survey or the Medical Outcome
Short Form Survey. Had you done so, you may have
reported your results in a slightly different manner. These
tools have questions regarding how the patient felt about
their care and how their general health was after the
surgery compared with what it was before the surgery. It
is conceivable that the patients might still have opted for
the infrainguinal bypass procedure in spite of some of the
sobering data you have presented.
Do you believe that any of the quality of life assess-
ment tools that are available today are appropriate to be
used in our patients who have critical limb ischemia? If a
vascular surgeon wanted to incorporate this kind of assess-
ment in his practice, which tool do you think would be
most helpful? There has been some criticism that the tra-
ditional outcome assessment tools are inappropriate for
our patients because our patients are older, have many
medical problems, and by the time they reach the point of
critical limb ischemia they may be on a downward curve as
far as their functional outcome and longevity.
You have listed in your paper many of the demo-
graphic descriptions of your patients. I think that these
may explain some of your results. For example, 66% of the
patients had ulcer gangrene, 53% had diabetes mellitus,
20% had had a previous ipsilateral bypass, and 60% of your
bypass grafts were to the tibial or pedal level. Based on
your experience with these patients, are you starting to
form a profile of patients in whom you anticipate the
results might be particularly bad?
I believe your assessment of these patients represents a
very comprehensive and honest assessment of the results
of infrainguinal bypass surgery for critical limb ischemia.
Of course, a comparative treatment such as nonoperation
or primary amputation is an option, but do you have any
data that either of these two options will result in a better
quality-of-life assessment in these critically ill patients?
There is no question that bypass surgery for limb-
threatening ischemia is an effective way of rehabilitating
some patients and improving their functional status. There
are some patients, however, in whom serious considera-
tion needs to be given before recommending vascular
reconstruction. Outcome studies such as that reported
today will serve to help the clinician gather valuable infor-
mation that may be helpful in establishing guidelines that
will result in improving the quality of life of patients who
have peripheral arterial occlusive disease.
Dr. Alexander D. Nicoloff. Thank you, Dr. Menzoian.
With regard to your first question, there have been many
studies that use questionnaires to analyze outcome after
leg bypass surgery for both claudication and limb salvage.
The results have been mixed. Although I think that this is
an appropriate way to measure the outcomes, we tried to
measure it from the point of view of the patient and in an
objective manner, particularly by looking at the need for
repeat operations and wound healing. The questionnaires,
including the Short Form 36 and the Rand questionnaire
are subjective and could be biased in some instances.
In response to your question about patient profiles and
whether we identified one that would suggest proceeding
with alternate therapy, we did not address that specifically
in this study. Certainly there were some groups that stood
out, for instance, patients with diabetes and renal failure,
which may not be a surprise to most of us. Further study is
needed to define these subgroups individually.
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And with regard to your last question, no, we don’t
have any data in our study on alternate therapies. That will
doubtless be the focus of a future study.
Dr. Keith D. Calligaro (Philadelphia, Pa.). I just have
a comment to make. The data you have presented have
several significant and, I might say, potentially dangerous
implications. In this era of increasing impact of third-party
payers and subsequent decreasing reimbursements, those
same third-party payers may use these data to suggest
what seems to be your ultimate conclusion: that patients
with severely ischemic limbs not be subjected to revascu-
larization but simply undergo a primary amputation,
which would obviously have profound implications on
everyone in this room.
My comment is only that I would request that in your
manuscript you carefully mention that the outcome of pri-
mary amputations in this same patient group is not really
well known. And I might dare to say that almost all of
those patients might suggest to you that not having their
limb is significantly worse than what they have gone
through to achieve limb salvage.
Dr. Nicoloff. Thank you. It is true that we did not look
at what patients think of bypass surgery compared with pri-
mary amputation. And most assuredly, we are not making
any recommendations to change practice policies. The pur-
pose of the study was simply to determine how these
patients fared over the long term after limb salvage surgery.
We conclude that they fared poorly. We most assuredly are
not concluding that any alternative therapy is better.
Dr. George Andros (Encino, Calif.). I would like to
congratulate the authors on addressing important out-
comes apart from the ones we traditionally use. When we
looked at our plantar bypass procedures several years ago
in patients with diabetes, we found that a full 30% of those
people returned to work. I am wondering whether you
investigated another useful outcome: how many people
actually return to work in this group, even though the
mean age was over 65 years.
I am also a little troubled by any suggestion that we
approach these patients with the recommendation for pri-
mary amputation on other than a very selective basis. Your
data seemed to support being very cautious about the use
of primary amputation because you did point out that the
most common repeat operation was an operation on the
other leg, so you’ve already got two limbs in play. I’d like
you to comment on that.
Dr. Nicoloff. Thank you. In our cohort all but a tiny
percentage of patients had retired, so return to work was
not a valid endpoint. We did not include this parameter in
our study.
With regard to your second question, we do not sug-
gest approaching these patients with the recommendation
of primary amputation. Further subgroup analysis, beyond
the scope of this study, will be required to even address
this issue.
Dr. Frank W. LoGerfo (Boston, Mass.). I want to
compliment you on your very nice presentation and for
revisiting the palliative nature of what we do in lower
extremity arterial reconstruction and, hence, our conserv-
ative attitude towards operating on these patients.
I have just one concern about your data. This is a very
small number of patients out of the large denominator, of
course, that are done at OHSU. The single criterion, as I
understand it, was that they underwent their initial bypass
procedure at OHSU. One of the things that aroused my
concern about this is the mortality rate, 6%, which is high-
er, I believe, than has been reported in previous publica-
tions. I also noticed in the abstract that there were 77
patients at the time it was written, with two deaths. Pre-
sented here are 112 patients with seven deaths. So that, by
my calculations, of those 35 patients who were added five
died, or a 14% operative mortality rate. So I just wondered
about that. Is there something about this cohort that is
extremely high-risk as compared with the broader number
of patients who undergo this operation?
Finally, I do think that it is important to say that this
is something that may be true but only somewhat related
to whether we should operate on these patients. We can
still perform arterial reconstruction with a low mortality
rate, a high patency rate, and we can save their legs.
Dr. Nicoloff. Yes, the operative mortality rate of the
patients, at 6%, is higher than in previous studies that we
have presented. I have no way to really explain this other
than that this study looks at a 3-year interval of consecu-
tive operations performed about 5 years ago, whereas the
other previously reported data are over a longer period—
10 years or so. So I have no explanation of why the mor-
tality rate is higher in these consecutive patients over the
relatively short 3-year study interval. But with regard to
other demographics, risk factors, and morbidity, this study
group is substantially the same as the previous populations
that we have studied.
The lower operative mortality rate in the preliminary
abstract to which you refer was calculated before obtain-
ing complete follow-up on many patients, three or four of
whom were found to have died after hospital discharge
but within the 30-day operative period, which accounts
for the difference in the mortality figure.
Dr. James M. Malone (Phoenix, Ariz.). Once again,
Dr. Porter’s group has given us a very provocative paper,
and it would indeed be interesting to see randomization
between amputation and limb bypass surgery. Of all the
people in the audience who can speak to lower limb ampu-
tation, I should probably be the one to rise to say that
limb amputation also has measurable standards much like
distal bypass grafting does, as presented in this paper. As
amputation surgeons, we don’t think in terms of patency,
but we do think in terms of continued successful ambula-
tion, avoidance of pain, and avoidance of reoperation.
Long-term results from our immediate postoperative
prosthesis fit group demonstrate remarkably similar data.
About half of the patients are dead at 5 years. Approxi-
mately 98% of the surviving patients still continue to
ambulate, an observation that would at first glance per-
haps suggest that amputation would be the treatment of
choice. However, the whole issue really revolves around
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the ideal of what is trying to be accomplished. If you
would ask the individual with an amputation whether
walking is satisfactory, I would think that the mass of our
patients would answer yes. The complexing issue, obvi-
ously, is whether it is ideal to be able to ambulate or to
keep your leg? I don’t think any of us are going to be able
to solve that dilemma today.
In addition, as one other discussant mentioned, it is
very depressing when every time you perform a distal
bypass procedure you are cautioned by your hospital
CEO that the hospital has lost money, and yet every time
you perform a primary amputation and get the patient
out the door walking you are congratulated for saving the
hospital money. The paper was very provocative and very
well presented.
Dr. Nicoloff. Thank you. A considerable amount of lit-
erature indicates that primary amputation has an outcome
equal to or slightly worse than that of limb salvage attempts.
One reason for this is that patients who undergo primary
amputation tend to have more comorbidities and are sicker.
It is difficult to compare these patient groups because a
prospective, randomized study of revascularization com-
pared with primary amputation cannot be performed.
There is one study by Hoghton and his associates that
showed that patients who underwent amputation after
failed revascularization maintained their mobility better in
comparison with patients who underwent revasculariza-
tion. This might be a closer match than comparing
patients who undergo revascularization with patients
selected for primary amputation.
It is important to keep in mind that we are in no way
recommending primary amputation. Our only objective
was to attempt to accurately describe what happened to
this cohort after limb salvage surgery.
Dr. Gary R. Seabrook (Milwaukee, Wis.). A study of
functional outcomes in our patients would agree with the
findings of your report. In data presented at the Midwest-
ern Vascular Society meeting 2 years ago, we sought to
measure function and health-related quality of life using a
modification of the SF-36. In fact, that instrument can be
difficult to administer to an elderly population because of
the complexity of the rating scales, and some questions
simply don’t pertain to the activities of these older adults.
We have found that patients who have undergone suc-
cessful arterial revascularization for limb salvage are as
functional as age-matched controls only in tasks of dress-
ing themselves and using the toilet when assessed for a
wide variety of physical activities. Patients who have
undergone infrainguinal bypass grafting perform very sim-
ilarly to amputees with functional prostheses.
These data should not discourage us from performing
operations for limb salvage or investigating their out-
comes. We need to document that our patients are, in fact,
very disabled even when their limbs have been preserved.
This information identifies the vast amount of care that
these patients will require for their lifetime.
Dr. Nicoloff. Thank you, Dr. Seabrook, for your com-
ments. I agree with them completely, as they basically
describe the bottom line of our paper. Not only does this
information support the vast amount of care that these
patients will need, but hopefully will also help in further
advising patients and referring physicians of what is
involved over the long term when infrainguinal bypass
grafting for limb salvage is undertaken.
